- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/65 - Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Patent holdings for IPC class C07K 14/65
Total number of patents in this class: 328
10-year publication summary
|
23
|
20
|
25
|
28
|
19
|
26
|
25
|
15
|
26
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Silver Creek Pharmaceuticals, Inc. | 30 |
20 |
| Takeda Pharmaceutical Company Limited | 2719 |
17 |
| BioMarin Pharmaceutical Inc. | 383 |
15 |
| Amicus Therapeutics, Inc. | 356 |
12 |
| Novartis AG | 10350 |
11 |
| Biocon Limited | 222 |
10 |
| Versameb AG | 20 |
8 |
| Cavalry Biosciences, Inc. | 13 |
8 |
| The Brigham and Women's Hospital, Inc. | 2258 |
6 |
| IGF Oncology, LLC | 15 |
6 |
| Juvena Therapeutics, Inc. | 19 |
5 |
| Upside Foods, Inc. | 139 |
5 |
| Oak Hill Bio Limited | 29 |
5 |
| F. Hoffmann-La Roche AG | 7828 |
4 |
| The Trustees of the University of Pennsylvania | 4398 |
4 |
| Julius-maximilians-universitat Wurzburg | 280 |
4 |
| Universitat Autonoma de Barcelona | 332 |
4 |
| University of Vermont and State Agricultural College | 393 |
4 |
| In3bio Ltd. | 23 |
4 |
| Hoffmann-La Roche Inc. | 3679 |
3 |
| Other owners | 173 |